OTCM
HLTT
Market cap10kUSD
Nov 10, Last price
0.00USD
Name
Healthtech Solutions Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Healthtech Solutions, Inc., through its subsidiaries, operates as a life sciences company. It focuses on the development of wound care products for acute and chronic wounds, including AmnioBind, a placental membrane allograft for burns and non-healing wounds, such as diabetic foot ulcers. The company also engages in the development of ultrasound imaging and artificial intelligence-based image analysis software for the applications in treatment of chest and musculoskeletal system. In addition, it is developing software technology that compares a healthy heart rhythm electronic signal with a damaged heart's signal that derives an electronic signal representing the curative waveform. The company was founded in 2018 and is based in Tuckahoe, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2020‑06 | |
| Income | ||||
Revenues | ||||
Cost of revenue | ||||
Unusual Expense (Income) | ||||
NOPBT | ||||
NOPBT Margin | ||||
Operating Taxes | ||||
Tax Rate | ||||
NOPAT | ||||
Net income | ||||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | ||||
Long-term debt | ||||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | ||||
| Cash flow | ||||
Cash from operating activities | ||||
CAPEX | ||||
Cash from investing activities | ||||
Cash from financing activities | ||||
FCF | ||||
| Balance | ||||
Cash | ||||
Long term investments | ||||
Excess cash | ||||
Stockholders' equity | ||||
Invested Capital | ||||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | ||||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | ||||
EV/EBITDA | ||||
Interest | ||||
Interest/NOPBT | ||||